Set on the historic Walter Reed Army Medical Center, the Children’s National Research & Innovation Campus will be a one-of-kind innovation hub. The nearly 12-acre campus will house leading entrepreneurs, [….]
The new hub, dubbed JLABS @ Washington, D.C., will host up to 50 startups spanning pharmaceuticals, medical devices, consumer and health tech companies, including those working on pediatric care. The first group of companies moving in include spinouts from the Children’s National Health System, J&J’s partner in running the site, startups local to the D.C. area and those from other parts of the country.
For entrepreneurs and early stage companies, raising capital can be challenging. For female entrepreneurs it can be even more challenging as they can experience gender bias in their efforts to [….]
Expanding the mechanisms for administering therapeutics and vaccines may have the potential to disrupt the status quo and improve availability and accessibility of therapeutic and preventive treatments. This session will [….]
In seeking to combat emerging infectious diseases and other 21st-century health threats, the path to better prepared, protected, and healthy individuals, families, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call.
Approximately 300,000 children from infancy to age 14 are diagnosed with cancer worldwide every year . Although cure rates for some pediatric cancers have increased to about 80% in recent [….]
National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners
National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) recently announced the winners of its annual [….]
As the COVID-19 pandemic continues to spread across the world, reports on the unique experience of COVID-19 in children are starting to emerge. Most recently, a rare, but serious condition [….]
In Conversation: Sally Allain, Head, JLABS @ Washington, DC – Johnson & Johnson Innovation BioBuzz recently caught up with the Head of JLABS @ Washington, DC, Sally Allain, to discuss [….]